Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Ribosome Profiling

Ribosome Profiling

Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients.

Blood cancer journal·2026

Same author

Peripheral blood immune cell profiling and response to BCMA CAR-T cell therapy in relapsed refractory multiple myeloma.

Blood cancer journal·2026

Same author

Equal survival for Black Americans with multiple myeloma when appropriately matched to White Americans.

Blood cancer journal·2025

Same author

The invisible divide: the impact of racial and geographic disparities on multiple myeloma outcomes - insights from a single-site study.

Haematologica·2025

Same author

Prognostic impact of focal lesion location and persistence in multiple myeloma: insights from serial PET/DWI imaging.

Blood advances·2025

Same author

Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myeloma.

Cancer biomarkers : section A of Disease markers·2025

Same journal

Modified short-course fludarabine-based conditioning regimen for salvage cord blood transplantation after graft failure.

International journal of hematology·2026

Same journal

Cytarabine-based induction and oral maintenance therapy for a single system with single-site Langerhans cell histiocytosis.

International journal of hematology·2026

Same journal

Long-term treatment-free remission in CML after early dasatinib discontinuation due to interstitial pneumonitis.

International journal of hematology·2026

Same journal

Correction to: Low reticulocyte count at infusion is a risk factor for high-grade cytokine release syndrome in chimeric antigen receptor T cell therapy.

International journal of hematology·2026

Same journal

The efficacy of prophylactic tranexamic acid in patients with hematologic malignancy: a systematic review and meta-analysis.

International journal of hematology·2026

Same journal

Current status and challenges of TCR-T cell therapy for AML/MDS.

International journal of hematology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Feb 22, 2026

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

Global gene expression profiling in the study of multiple myeloma.

John D Shaughnessy¹

¹Donna D. and Donald M. Lambert Laboratory of Myeloma Genetics, Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences Little Rock, Arkansas 72205, USA. shaughnessyjohn@uams.edu

International Journal of Hematology

|May 7, 2003

Summary

This summary is machine-generated.

This study explores the molecular basis of multiple myeloma (MM), a plasma cell cancer. By analyzing gene expression, researchers aim to understand MM development, clinical variability, and treatment resistance.

More Related Videos

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

Related Experiment Videos

Last Updated: Feb 22, 2026

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

Area of Science:

Oncology
Molecular Biology
Genetics

Background:

Multiple myeloma (MM) is a fatal plasma cell malignancy with poorly understood development and clinical variability.
Current treatments' mechanisms and comorbidities like bone lesions remain largely unknown.
The transition from monoclonal gammopathy of undetermined significance (MGUS) to MM is not well-defined.

Purpose of the Study:

To investigate the molecular mechanisms underlying multiple myeloma (MM) development and progression.
To identify molecular factors contributing to MM's clinical course variability and treatment resistance.
To explore the molecular triggers for the progression from MGUS to MM.

Main Methods:

High-throughput global gene expression profiling of normal plasma cells, MGUS, and MM.
Transcriptome analysis to dissect molecular differences and identify key genes.
Correlation of gene expression patterns with clinical behaviors and outcomes.

Main Results:

Recent progress in understanding MM molecular biology through transcriptome analysis.
Identification of potential molecular events in MM initiation and progression.
Insights into the variability of MM clinical courses and potential therapeutic targets.

Conclusions:

Global gene expression profiling is crucial for understanding MM's complex biology.
Transcriptome dissection offers new avenues for diagnosing and treating MM.
Further research is needed to fully elucidate MM pathogenesis and guide therapeutic strategies.